newsfilter
← Latest News
GlobeNewswire·

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic